Genen­tech to halt com­mer­cial man­u­fac­tur­ing in Cal­i­for­nia HQ, with lay­offs at­tached

Genen­tech is halt­ing com­mer­cial man­u­fac­tur­ing at its Cal­i­for­nia head­quar­ters — and lay­ing off sev­er­al hun­dred em­ploy­ees.

The move is the re­sult of a de­ci­sion Genen­tech made in 2007 to re­lo­cate its com­mer­cial man­u­fac­tur­ing op­er­a­tions from its South San Fran­cis­co head­quar­ters said An­di God­dard, Genen­tech’s SVP of qual­i­ty and com­pli­ance for phar­ma­ceu­ti­cal tech­ni­cal op­er­a­tions, in an in­ter­view with End­points News. Genen­tech will pro­duce med­i­cines at its new clin­i­cal sup­ply cen­ter, which opened in South San Fran­cis­co last year while many of its com­mer­cial prod­ucts will be made at oth­er pro­duc­tion sites or by con­tract man­u­fac­tur­ers.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN